Axel Hauschild - Department of Dermatology, University Hospital Schleswig-Holstein (UKSH)

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

European Consensus-Based Interdisciplinary Guideline for Melanoma. Part 1: Diagnostics - Update 2024

Claus Garbe,Teresa Amaral, Ketty Peris,Axel Hauschild, Petr Arenberger, Nicole Basset-Seguin, Lars Bastholt,Veronique Bataille, Lieve Brochez, Veronique del Marmol,Brigitte Dréno,Alexander M.M. Eggermont, Maria Concetta Fargnoli,Ana-Maria Forsea,Christoph Höller,Roland Kaufmann, Nicole Kelleners-Smeets,Aimilios Lallas,Celeste Lebbé, Ulrike Leiter

European Journal of Cancerpp.115152, (2024)

引用0浏览0WOS引用

An Update on Access to Novel Treatment for Metastatic Melanoma in Europe — A 2024 Survey of the European Melanoma Registry and the European Association of Dermato-Oncology

L Kandolf,P Ascierto,L Bastholt, I Gavrilova,J Haanen,A Hauschild,D Herceg,C Hoeller, A Jalovcic Suljevic, JI Kessels,I Krajsova,M Kukushkina,A Lallas,P Lorigan,J Mangana,I Marquez-Rodas, L Mazilu,P Mohr, M Bylaite-Bucinskiene,J Ocvirk

European journal of cancer (Oxford, England 1990) (2024): 115124-115124

引用0浏览0WOS引用

European Consensus-Based Interdisciplinary Guideline for Melanoma. Part 2: Treatment - Update 2024

Claus Garbe,Teresa Amaral, Ketty Peris,Axel Hauschild, Petr Arenberger, Nicole Basset-Seguin, Lars Bastholt,Veronique Bataille, Lieve Brochez, Veronique del Marmol,Brigitte Dréno, Alexander M.M. Eggermont, Maria Concetta Fargnoli,Ana-Maria Forsea,Christoph Höller,Roland Kaufmann, Nicole Kelleners-Smeets,Aimilios Lallas,Celeste Lebbé, Ulrike Leiter

European Journal of Cancerpp.115153, (2024)

引用0浏览0WOS引用

Using Multiple Dermoscopic Photographs of One Lesion Improves Melanoma Classification Via Deep Learning: A Prognostic Diagnostic Accuracy Study

Achim Hekler,Roman C. Maron,Sarah Haggenmüller,Max Schmitt,Christoph Wies, Jochen Utikal, Friedegund Meier,Sarah Hobelsberger,Frank Friedrich Gellrich,Mildred Sergon,Axel Hauschild,Lars E. French, Lucie Heinzerling,Justin Gabriel Schlager,Kamran Ghoreschi,Max Schlaak,Franz J. Hilke,Gabriela Poch,Sören Korsing,Carola Berking,Markus V. Heppt,Michael Erdmann, Sebastian Haferkamp,Konstantin Drexler,Dirk Schadendorf,Wiebke Sondermann,Matthias Goebeler,Bastian Schilling,Jakob N. Kather,Eva Krieghoff‐Henning, Titus J. Brinker

arXiv (Cornell University) (2023)

引用0浏览0引用

Dermatologic Adverse Events Associated with Afatinib: an Oral ErbB Family Blocker

Mario E. Lacouture,Dirk Schadendorf,Chia‐Yu Chu,Martina Uttenreuther‐Fischer,Uz Stammberger,Dennis O’Brien,Axel Hauschild

Expert review of anticancer therapyno. 6 (2013): 721-728

引用0浏览0引用

Vemurafenib Improves Overall Survival Compared to Dacarbazine in Advanced BRAFV600E Mutated Melanoma: an Update from the Phase III Randomized, Open-Label, Multicenter BRIM3 Trial

Axel Hauschild,McArthur Ga,Caroline Robert,Haanen Jb,Paolo A. Ascierto, James Larkin,Reinhard Dummer,Claus Garbe, Alberto Testori,Maio Michele,David Hogg,Paul Lorigan,Célèste Lebbe, Thomas Jouary,Dirk Schadendorf, A. Ribas,S. O’Day, Sosman Ja,John M. Kirkwood,A Eggermont,Brigitte Dréno,K. B. Nolop,Li J,Betty J Nelson, Jan Janča, Lee Rj, KT Flaherty, PB Chapman

openalex（2011）

引用0浏览0引用

Phase III Randomized, Open-Label, Multicenter Trial (BRIM3) Comparing BRAF Inhibitor Vemurafenib with Dacarbazine (DTIC) in Patients with V600E BRAF-mutated Melanoma (ASCO 2011 Melanoma, Abstract LBA4)

Paul Lorigan,Paul B. Chapman,Axel Hauschild,Caroline Robert,James Larkin, J.B.A.G. Haanen, A. Ribas,David Hogg, Steven O’Day,Paolo A. Ascierto,Alessandro Testori,Reinhard Dummer, J. A. Sosman,Claus Garbe, R. J. Lee, K. B. Nolop, B. Nelson,Jean‐Jacques Grob, Keith T. Flaherty, Grant A. McArthur

openalex（2011）

引用0浏览0引用

Update on Immunologic Therapy with Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management

Katharina C. Kaehler,Sarah Piel,Elisabeth Livingstone,Bastian Schilling,Axel Hauschild,Dirk Schadendorf

Seminars in oncology（2010）

引用161浏览0引用

161

Efficacy of Vemurafenib in BRAFV600K Mutation Positive Melanoma Disease - Results from the Phase III Clinical Study BRIM-3

PB Chapman,Axel Hauschild,Caroline Robert,Jmg Larkin, J.B.A.G. Haanen,Antoni Ribas,David Hogg,Omid Hamid, P.A. Ascierto, Alberto Testori,Paul Lorigan,Reinhard Dummer, J. A. Sosman,Claus Garbe,Michele Maio,KB Nolop, B J Nelson, A. K. Joe,Ming Yin, K.T. Flaherty, Grant A. McArthur

semanticscholar

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn